Evidence map›Paper›PMID 27271593›Full record

SynthesisInternational journal of molecular sciences2016

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis.

Ayala Shirazi, Brendon Stubbs, Lucia Gomez, Susan Moore, Fiona Gaughran, Robert J Flanagan, James H MacCabe, John Lally

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pharmacological treatment for antipsychotic-related constipation.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Constipation and Psychiatric Disorders: A Bidirectional Mendelian Randomization Study.Combinatorial chemistry & high throughput screening · 2026
    Article
  11. Article
  12. Management of Constipation in Eating Disorders-A Scoping Review.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Off-label Prescribing of Clozapine and Safety.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2025
    Review
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ayala ShiraziGKT School of Medical Education Department, King's College London University, London SE1 1UL, UK. ayala.shirazi@kcl.ac.uk.
Brendon StubbsHealth Service and Population Research Department, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK. brendon.stubbs@kcl.ac.uk.
Lucia GomezGKT School of Medical Education Department, King's College London University, London SE1 1UL, UK. lucia.gomez@kcl.ac.uk.
Susan MooreDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK. susan.moore@kcl.ac.uk.
Fiona GaughranDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK. fiona.p.gaughran@kcl.ac.uk.
Robert J FlanaganToxicology Unit, Department of Clinical Biochemistry, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK. robert.flanagan@nhs.net.
James H MacCabeDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK. james.maccabe@kcl.ac.uk.
John LallyDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK. john.lally@kcl.ac.uk.
King's College London · GBKing's College Hospital NHS Foundation Trust · GBSouth London and Maudsley NHS Foundation Trust · GBUniversity of London · GB

Funding

Medical Research Council MC_PC_13065Medical Research Council MR/L003988/1Medical Research Council MR/L011794/1
6 · The paper itself

Abstract

Constipation is a frequently overlooked side effect of clozapine treatment that can prove fatal. We conducted a systematic review and meta-analysis to estimate the prevalence and risk factors for clozapine-associated constipation. Two authors performed a systematic search of major electronic databases from January 1990 to March 2016 for articles reporting the prevalence of constipation in adults treated with clozapine. A random effects meta-analysis was conducted. A total of 32 studies were meta-analyzed, establishing a pooled prevalence of clozapine-associated constipation of 31.2% (95% CI: 25.6-37.4) (n = 2013). People taking clozapine were significantly more likely to be constipated versus other antipsychotics (OR 3.02 (CI: 1.91-4.77), p < 0.001, n = 11 studies). Meta-regression identified two significant study-level factors associated with constipation prevalence: significantly higher (p = 0.02) rates of constipation were observed for those treated in inpatient versus outpatient or mixed settings and for those studies in which constipation was a primary or secondary outcome measure (36.9%) compared to studies in which constipation was not a specified outcome measure (24.8%, p = 0.048). Clozapine-associated constipation is common and approximately three times more likely than with other antipsychotics. Screening and preventative strategies should be established and appropriate symptomatic treatment applied when required.

Indexed as

Antipsychotic AgentsClozapineConstipationHumansOdds RatioPrevalenceSchizophreniaSerotonin AntagonistsAntipsychotic AgentsClozapineSerotonin Antagonistsadverse eventsclozapineconstipationmeta-analysissystematic reviewtreatment-resistant schizophrenia

Identifiers

PMID27271593
PMCPMC4926397
OpenAlexW2416606270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.